Inpare ApS: Financial statements 2019
CVR: 37138789
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Inpare ApS (CVR 37138789) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -99,901 and a net result of DKK -77,923 compared with DKK -26,070 the year before. Equity in the 2019 report amounted to DKK -110,485. The company had 2 employees in the financial year.
- Gross Profit
- DKK -99,901
- Profit/Loss
- DKK -77,923
- Equity
- DKK -110,485
- Total Assets
- DKK 36,090
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -100K | -78K | -110K | 2 |
| 2018 | - | -27K | -26K | -33K | 2 |
| 2017 | 0 | -168K | -133K | -6K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Inpare ApS has published its annual report for 2018. Gross profit came to DKK -27,013, and the net result was DKK -26,070.
About Inpare ApS
Inpare ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 27 November 2024. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Lionheart Pharmaceuticals ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -218,796 and a net result of DKK -272,847 compared with DKK -142,714 the year before. Equity in the 2023 report amounted to DKK -735,535.